Abbott Laboratories, infant formula
Digest more
Abbott has agreed to pay $385 million to resolve allegations that it supplied formula that did not meet required safety and manufacturing standards.
Analysts keep raising their price targets on this 54-year dividend raiser. Here are the reasons behind the newfound confidence.
On September 17, 2026, Abbott Laboratories’ board of directors declared a quarterly common dividend of USD 0.63 per share, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results